Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-CDK7 Antibody (R1Y08)

Catalog #:   RHE78201 Specific References (47) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: WB
Accession: P50613
Overview

Catalog No.

RHE78201

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

WB: 1:1000-1:2000

Target

CAK1, Cyclin-dependent kinase 7, MO15, p39 Mo15, STK1, CDKN7, CDK7, CDK-activating kinase 1, 39 kDa protein kinase, TFIIH basal transcription factor complex kinase subunit, Cell division protein kinase 7, CAK, Serine/threonine-protein kinase 1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P50613

Applications

WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1Y08

Data Image
  • Western blot
    Western blot analysis of CDK7 expression in MCF-7 cell lysate.
References

Antibody-drug conjugates targeting SSEA-4 inhibits growth and migration of SSEA-4 positive breast cancer cells., PMID:39798832

DNp73 enhances tumor progression and immune evasion in multiple myeloma by targeting the MYC and MYCN pathways., PMID:39380995

Selective but not pan-CDK inhibition abrogates 5-FU-driven tissue factor upregulation in colon cancer., PMID:38719932

Cytomegalovirus cyclin-dependent kinase ortholog vCDK/pUL97 undergoes regulatory interaction with human cyclin H and CDK7 to codetermine viral replication efficiency., PMID:37591314

An Overview of CDK Enzyme Inhibitors in Cancer Therapy., PMID:36959160

Inhibition of MYC suppresses programmed cell death ligand-1 expression and enhances immunotherapy in triple-negative breast cancer., PMID:36583862

Systematic illumination of druggable genes in cancer genomes., PMID:35196490

CDK inhibitors in cancer therapy, an overview of recent development., PMID:34094661

Advances in Therapy for Hormone Receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer Patients Who Have Experienced Progression After Treatment with CDK4/6 Inhibitors., PMID:33976551

G1 Cell Cycle Arrest and Extrinsic Apoptotic Mechanisms Underlying the Anti-Leukemic Activity of CDK7 Inhibitor BS-181., PMID:33352782

CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer., PMID:32690037

Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma., PMID:32653773

Inhibition of cyclin-dependent kinase 7 down-regulates yes-associated protein expression in mesothelioma cells., PMID:31755214

Transcriptional targeting of oncogene addiction in medullary thyroid cancer., PMID:30135308

Selective inhibition of CDK7 ameliorates experimental arthritis in mice., PMID:25149277

Nascent histamine induces α-synuclein and caspase-3 on human cells., PMID:25124665

Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation., PMID:19487459

A scoring system for the follow up study of nuclear receptor coactivator complexes., PMID:16862220

Cyclin-dependent kinase activating kinase/Cdk7 co-localizes with PKC-iota in human glioma cells., PMID:15695176

[Analysis of transient G1/S arrest in E1A+E1B-19kDa transformed cells after ionizing radiation]., PMID:15027353

Two forms of RNA polymerase II holoenzyme display different abundance during the cell cycle., PMID:12615059

Functional coupling of capping and transcription of mRNA., PMID:12408827

Protein phosphatase-1 dephosphorylates the C-terminal domain of RNA polymerase-II., PMID:12185079

Cyclin H is a new binding partner for protein kinase CK2., PMID:12147220

Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera., PMID:12118371

Molecular cloning and characterisation of p15(CDK-BP), a novel CDK-binding protein., PMID:12007796

Modulation of MDM2/p53 and cyclin-activating kinase during the megakaryocyte differentiation of human erythroleukemia cells., PMID:11823051

Strong functional interactions of TFIIH with XPC and XPG in human DNA nucleotide excision repair, without a preassembled repairosome., PMID:11259578

Molecular structure of human TFIIH., PMID:11007478

Interactions of Cdk7 and Kin28 with Hint/PKCI-1 and Hnt1 histidine triad proteins., PMID:10958787

Analysis of CAK activities from human cells., PMID:10866826

Transforming growth factor beta targeted inactivation of cyclin E:cyclin-dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activity., PMID:10611320

The disappearance of cyclins A and B and the increase in activity of the G(2)/M-phase cellular kinase cdc2 in herpes simplex virus 1-infected cells require expression of the alpha22/U(S)1.5 and U(L)13 viral genes., PMID:10590085

A rice homolog of Cdk7/MO15 phosphorylates both cyclin-dependent protein kinases and the carboxy-terminal domain of RNA polymerase II., PMID:10036778

An RNA polymerase II complex containing all essential initiation factors binds to the activation domain of PAR leucine zipper transcription factor thyroid embryonic factor., PMID:9891058

Heat-shock-specific phosphorylation and transcriptional activity of RNA polymerase II., PMID:9665818

Differential expression of G1 cyclins and cyclin-dependent kinase inhibitors in normal and transformed melanocytes., PMID:9579467

Changes in cyclin B during oocyte maturation and early embryonic cell cycle in the newt, Cynops pyrrhogaster: requirement of germinal vesicle for MPF activation., PMID:9520324

Introduction of cyclin B induces activation of the maturation-promoting factor and breakdown of germinal vesicle in growing zebrafish oocytes unresponsive to the maturation-inducing hormone., PMID:9331337

The cdk7-cyclin H-MAT1 complex associated with TFIIH is localized in coiled bodies., PMID:9243502

Translocation of cdk2 to the nucleus during G1-phase in PDGF-stimulated human fibroblasts., PMID:9141623

Regulation of CDK7 substrate specificity by MAT1 and TFIIH., PMID:9130709

Protein kinase C inhibits the CAK-CDK2 cyclin-dependent kinase cascade and G1/S cell cycle progression in human diploid fibroblasts., PMID:9244189

Biochemical characterization of the human cyclin-dependent protein kinase activating kinase. Identification of p35 as a novel regulatory subunit., PMID:8550604

A mammalian RNA polymerase II holoenzyme containing all components required for promoter-specific transcription initiation., PMID:7553866

Cdk-activating kinase complex is a component of human transcription factor TFIIH., PMID:7533895

Molecular cloning of the human CAK1 gene encoding a cyclin-dependent kinase-activating kinase., PMID:8208556

Datasheet

Document Download

Anti-CDK7 Antibody (R1Y08).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-CDK7 Antibody (R1Y08) [RHE78201]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only